Clinical Trial Update: Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes [Phase 1]

View source ↗

Summary

Phase 1 trial update (completed) on the combination of vosaroxin and azacitidine in myelodysplastic syndromes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Vosaroxin (vosaroxin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED